The gender health gap: why women's pain gets dismissed
Women were formally excluded from most clinical research until the 1990s, which means much of modern medicine was built on data from male bodies. The consequences persist: women wait longer for diagnosis across many conditions, are more likely to have physical symptoms attributed to psychological causes, and are underrepresented in research on conditions that predominantly affect them. Knowing this is not cynicism. It is context that changes how you walk into an appointment.
The exclusion was written down
This is not folklore. In 1977, US regulatory guidance recommended excluding women of childbearing potential from early-phase drug trials. The stated reason was protecting potential pregnancies. The effect was that a generation of drugs was tested primarily on men and then prescribed to everyone.
It took until 1993, with the NIH Revitalization Act, for the inclusion of women in federally funded clinical research to be mandated in the US. That is well within the working lifetime of doctors practising today.
The knock-on effects are structural, not personal. Dosing, side effect profiles and symptom descriptions were often established without women in the sample. When your experience does not match the textbook, it is sometimes because the textbook was not written about you.
The Yentl syndrome
In 1991, cardiologist Bernadine Healy described what she called the Yentl syndrome: the phenomenon of women needing to present symptoms that look like a man's before being taken as seriously.
Heart attacks are the clearest example. The chest-clutching presentation is the male-typical one. Women more often present with nausea, jaw or back pain, shortness of breath and profound fatigue. Those symptoms are less likely to be immediately recognised as cardiac, and women have historically faced higher rates of misdiagnosis in emergency settings.
Pain gets read differently
Research has repeatedly found that women's pain reports are more likely to be attributed to emotional or psychological causes, and that women may wait longer for analgesia in emergency settings.
The most cited example in women's health is endometriosis, a condition affecting roughly one in ten women of reproductive age, where diagnostic delay is commonly reported at seven years or more. Seven years of being told that bad periods are normal.
Why it persists
Research funding has historically not tracked the burden of disease for conditions predominantly affecting women
Medical training covers menstrual health, perimenopause and menopause in far less depth than their prevalence would suggest
Appointment length. Complex, multi-system, fluctuating symptoms are exactly what a ten-minute appointment handles worst
The normalisation loop. Women are told symptoms are normal, so they stop reporting them, so prevalence data underestimates the problem, so it continues to look minor
What this means for you practically
Not "distrust doctors." Most are working inside a system with the gaps described above, not choosing them.
What it means is that the burden of specificity often falls on you:
Bring data, not descriptions. Tracked symptoms across cycles beat "it's been bad lately"
Lead with functional impact. Days missed, plans cancelled, things you can no longer do
Ask what is being ruled out. It moves the conversation from your credibility to clinical reasoning
Ask for documentation if you are sent away without a plan
Get a second opinion without treating it as disloyalty
The reason we write about this
OURbody exists because our founder was refused a basic breast exam at 24 despite family history, and was told it was not worth worrying about. That is one small story inside a very large pattern.
Tea does not fix a health system. Information helps you navigate one. For the practical version of this article, see how to talk to your doctor when you're being dismissed.
This article is educational and not medical advice.
